Conditions: Psoriasis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 150
Healthy volunteers: yes

Brief summary:
A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study.

Detailed description:
A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study to Compare the Safety and Efficacy of IDP-122 Lotion (0.01% halobetasol propionate) to Ultravate® (halobetasol propionate) Cream, 0.05% in the Treatment of Plaque Psoriasis.

Arms:
arm 1: Lotion arm 2: Cream arm 3: Lotion arm 4: Cream

Interventions: intervention 1: IDP-122 Vehicle Lotion intervention 2: IDP-122 Vehicle Cream intervention 3: IDP-122 Lotion intervention 4: Ultravate Cream
Intervention descriptions: intervention 1: Vehicle intervention 2: Vehicle intervention 3: Lotion intervention 4: Cream

Protocol document: